Andy Moye is a keynote speaker on leadership, AI, health economics, and precision medicine, and is the Co-founder and Chief Executive Officer of a stealth start-up AI company working in the cell and gene therapy space to bring life-saving medicines to patients. Andy is a former US Naval Flight Officer and served two combat deployments during the Global War on Terrorism (GWOT), including Operations Enduring Freedom and Operation Iraqi Freedom. He is the best-selling author of the book, From Bunker Hill to the Boardroom: Battle Tested Leadership for Today’s Executives, which tells the story of his family lineage through four generations of combat veterans and the enduring leadership lessons applied to today’s business world.

Andy has held roles as the Senior Vice-President and General Manager for Tempus AI, a company dedicated to improving patient outcomes through AI and data.  He was also the Chief Executive Officer and board member for Paige, a spinout company from Memorial Sloan Kettering Cancer Center in New York City that was acquired by Tempus.    Dr. Moye is passionate about making a difference in the fight against cancer, and has worked across the molecular diagnostics, biotechnology, Real World Data (RWD), and life sciences industries at the forefront of precision medicine in oncology.   

Andy Moye’s educational career includes a Bachelor of Science in Physiology from the University of Arizona, an MBA from the University of Florida, and a PhD in Health Economics from Walden University.   Andy has won numerous awards for leadership including Top 25 Healthcare Technology Leaders in Dallas and is an alumnus of the JPMorgan Chase 2024 CEOcircle cohort of the Institute for Veterans and Military Families, an executive program for veteran CEOs and entrepreneurs. He serves on the advisory boards of the University of Maryland Global Campus, CDx Diagnostics, and VistaPath.